Page 19 - Bauerfeind life 2013.2

life
magazine 2013/2
19
FOCUS
The individual adjustment
is unique”
Patients at the Orthopedic Clinic of St. Vincenz Hospital in Brakel, Germany, were provided
with the new Spinova orthoses following spinal surgery, making them among the first to
try out these aids. The Director of the clinic, Prof. Haaker, feels vindicated – both as a
clinician and as a member of the Spinova development team.
Would you say Spinova has enjoyed a success-
ful première at your clinic?
Prof. Haaker:
The aim was to establish
a solid basis for the new back treatment
platform right from the development phase.
With a great deal of effort, we have been
very successful in achieving this, including
in terms of determining indications. You see,
in the past there was a certain amount of
overlapping and lack of clarity, even in spe-
cialist medical literature. When should we
opt for lordosis, or delordosing treatment?
With Spinova, both of these are possible. If
the product proves convincing in practice, as
it has done at our clinic, we feel vindicated
in our decision to pursue its development.
Our efforts have paid off.
What kind of patients have you treated with
Spinova over the course of the observational
study?
Prof. Haaker:
Thanks to our nationwide
catchment area, we receive a large number
of patients with spinal conditions. These
range from fusion operations and the
straightening of vertebral bodies in the case
of osteoporotic fractures right through to
patients who have undergone intervertebral
disk surgery. All of them were provided with
a Spinova product as part of their post-
operative treatment. In around 70 percent
of cases, we used Spinova Immo Plus.
Like all Spinova orthoses, Spinova Immo
Plus has a modular construction and can be
dismantled bit by bit. What else do the new
orthoses offer that other back orthoses can‘t?
Prof. Haaker:
In most cases, our spine pa-
tients require stabilization and delordosing.
The new orthoses produce their effect with
pinpoint precision thanks to a special ten-
sioning strap system, which is attached to
the back setting device in variable positions.
The system is individually adjustable, which
is unique. The new tensioning strapping
enables a high, segment-specific exertion of
force, and this can be reproduced too. Cor-
rections are only necessary in extremely rare
cases, so there is a high level of therapeutic
reliability.
What is important in the case of fusion opera-
tions?
Prof. Haaker:
I would not like everything
to be concentrated on the metal implant in
the immediate post-operative phase. After
all, there are massive mechanical forces
involved, which impact on the new surgi-
cal construction. Particularly in the case of
aging patients, we worry whether the bones
will hold. So if I have an orthosis from the
Spinova range at my disposal that can pre-
vent harmful rotating movements, offers ex-
cellent wearing comfort and is not too bulky,
both the patient and I will be happy. After
six weeks the orthosis can be dismantled and
the patient mobilized, because the bone will
have built up by then. After three months of
wearing the orthosis, the patient will have
reached a good level of stability.
How do you treat the large number of inter-
vertebral disk patients?
Prof. Haaker:
They, too, were and still are
being treated with orthoses during post-
operative therapy. However, 15 percent of
our patients still receive purely conserva-
tive treatment. It is worth noting that we
normally have some intervertebral disk pa-
tients, about three to five percent, for whom
surgery appears to be indicated, primarily
those with neurological deficits. But we only
resort to surgery when all multi-modal ther-
apeutic approaches, which include orthoses,
have been exhausted. In general, however, I
always opt for conservative treatment before
surgical intervention, and in these cases in
particular I think the Spinova orthoses are a
good choice.
Prof. Rolf Haaker helped develop the Spinova range.
Observational study – post-operative treatment